1. Hypersensitivity reactions.
Prof. Mohamed Osman GadElRb.
College of Medicine & KKUH.

2. Introduction :
Immune reactions leading to pathological damage .( intense inflammatory responses ).
- Occur as :
1.Secondary heightened (increased) immune
responses .
OR:
2.Secndary inappropriate (abnormal ) immune
responses.

3. Four major categories according to Coombs and Gell classification :
Type I : Immediate H/S.
Type II : Cytotoxic H/S.
Type III : Immune – complex H/S.
Type IV : Delayed H/S.

4. are mediated by antibodies .
Types I , II and III :
are mediated by antibodies .
( The complement system become activated & contribute to tissue damage ).
Type IV :
Is generated by cell-mediated immune
responses.
( no complement activation )

5. Time course ; Hypersensitivity reactions differ in the rate at which they occur :
Type I : Can occur within minutes after exposure
to allergens .
Type II and III : time course , (4-8) hours to days .
Type IV : require days. ( delayed ).

6. Clinical presentation:
Hypersensitivity reactions :
- can occur as isolated reactions,
OR :
- more than one reaction may occur
in the same patient.
e.g. : Type I and Type III.

7. Type I Hypersensitivity.
Also termed :
*Immediate H/S ( can literally occur within minutes to hours ).
* Anaphylactic reactions .
OR :
* Allergic reactions.

8. Antibody isotype : IgE .(less frequently may be due to
Features :
Antibody isotype : IgE .(less frequently may be due to
STS IgG .)
Cellular components:
Mast cells , basophiles & eosinophils.
Antigens :
termed allergens ( antigens with low
molecular weight & highly soluble.)

9. Type I H/S. Evolved as a defense against parasitic infections.
( the hygiene theory ? )
* However , many reactions in some predisposed individuals are directed towards harmless molecules (allergens) and these individuals are said to be :
“atopic.”
( atopy : from the Greek atopos , meaning out of place ).

10. Atopy. Occur in certain genetically predisposed
individuals who develop one or more of the atopic diseases :
allergic rhinitis, asthma, and atopic dermatitis .
They comprise approx. 15 – 20 % of the
population .
Atopy tend to run in families .

11. - environmental factors.
The likelihood to generate a strong IgE response is
determined by :
- genetic factors .
- environmental factors.
these factor depend on exposure to allergens of diverse nature :
( pollens , foods , drugs
fungal spores , bee - sting venoms ,
house dust mites and animal dander).

12. Response to allergens in non-atopic individuals:
Adults and children without atopy mount a low – grade response , they produce allergen-specific IgG1 & IgG4. Persons with atopy ,by contrast, produce an exaggerated response characterized by production of : allergen –specific IgE antibodies.

13. Type I Reaction occur in 2 phases:
Phase I :
- Sensitization phase .
Allergen enter tissues , induce an
immune response . B – cells transform
to plasma cells & produce IgE.
- IgE bind to receptors on Mast cells and
basophiles ( F c ЄRI - high affinity receptors).
individuals become :
“ Sensitized . “

14. “ Degranulate”. Phase II : Challenge phase .
- Subsequent encounter with same allergen cross – link IgE on Mast cells .
- This generate an intracellular signal that prompts the Mast cells to:
“ Degranulate”.
(release mediators into the area of reaction).

16. Degranulation :
The release of a wide variety of mediators of inflammation .
These exert effects on surrounding target tissues.
There are 2 types :
1. primary mediators.
2. secondary mediators.

17. Primary mediators. 1. Histamine , heparin. 2. Serotonin .
3. Eosinophil chemotactic factor.
( ECF).
4. Neutrophil chemotactic factor (NCF ).
5. Proteases .

18. Secondary mediators :
1. Platelet activating factor . 2. Leukotriens ( slow reacting substance of anaphylaxis). 3. Prostaglandins . 4. Bradykinin. 5. Cytokines .( IL-1,TNF-a , IL-2 , 3, 4, 5, 6, )

19. Type 1 H/S. ( immediate hypersensitivity ).

20. Type 1 reactions result in :
* Vasodilatation and increased capillary
permeability .
* Edema.
* Vasoconstriction ( arteries and arterioles ).
* Bronchoconstriction.
* Increased mucus secretion.

21. deposit in nasopharyngeal and bronchial tissues result in :
Symptoms of type I reactions are determined by site of location of the allergens :
Inhaled allergens : 
deposit in nasopharyngeal and bronchial tissues result in :
- Allergic rhinitis.
- Allergic asthma.
Ingested allergens (oral route ) :
food allergy (G.I.T symptoms).

22. Bee sting allergens  Injected into the blood.
 Systemic inflammation.
 Anaphylactic shock.
(life - threatening).
Anaphylactoid reactions:-
are non - IgE mediated.
may result from contrast media or
local anesthetics.

23. Diagnosis:-
1. Skin prick test (SPT).
2. Intradermal test.
3. Specific IgE measurement (RAST).
4. Challenge test ( Nasal , Bronchial).
5. Elimination / Provocation test (Food allergy).

24. Skin prick test ( diagnosis of type 1 hypersensitivity ).

25. Type II Hypersensitivity. (Cytotoxic H/S).
Features:-
- IgG.
- Antigens ( Bound to cell membranes
or extra cellular matrix).
- source of antigens :
- Self - antigens.
- Exogenous antigens. (microbial ).
- Complement activation (Invariable).

26. Mechanisms of tissue damage in type 11:-
IgG (from blood) fix to tissue - bound antigen.
- Activate complement.
- Complement generate
chemotactic agents (C5a).
- Attract neutrophils and other
inflammatory cells.

27. Neutrophils bind to target through:-
A. Complement receptors -(immune -adherence). B. Antibody receptors - (Opsonic -adherence). - They secrete their enzymes to the outside (Exocytosis). - They cause direct damage.

28. Complement - mediated damage (type11):-
Activation of complement  C8 , C9.
- Membrane attack complex
(MAC).
- Direct lytic damage on target
\ tissues.

29. Mechanism of damage in type II H/S.

30. Type 11 H/S.( Glomerulonephritis anti-GBM ).

31. Clinical Examples ( type 11):-
1, Incompatible blood transfusion (ABO). -massive intravascular hemolysis of RBC. -Immediate reactions-IgM mediated. -Delayed reactions-(2-6 days ),IgG mediated. 2. Hemolytic disease of the new -born (HDN).

32. Diagnosis:-
- Detection of antibodies and antigens by Immunofluoresence in tissue biopsy specimens e.g. kidney , skin etc.

33. Type III Hypersensitivity ( immune – complex H/S .)
Features:-
- IgG or IgM.
- Soluble antigens.
- Immune – Complex formation.
- Complement activation.
(invariable).

34. Mechanism of tissue damage (type 111):-
Immune - Complexes are continuously forming.
- Depend on the nature and conc. of
antigens and antibodies.
- As long as they are not :-
- Extremely large.
- Numerous.
they are readily cleared.

35. Immune complex clearance :
1. The mononuclear- Phagocyte system.
- Macrophages and dendritic cells
degrade particles and debris.
2. Erythrocytes bind complexes via FcR1
receptors and release them in the liver.

36. When size and quantity over whelm the normal clearance mechanism:-
1. Complexes accumulate and deposit in
blood vessels and tissues.
2. They activate complement.
Therefore : induce immune - complex
disease.

37. Mechanism of tissue damage (type 111):
Complexes deposit in blood vessels and tissues and result in vasculitis , arthritis …et .
Two main types :
1. Complexes with antibody excess ,
are termed Arthus – type reactions .
( localized ).
2. Complexes with antigen excess ,
are termed serum – sickness reactions .
( systemic )

38. Type 111 H/S.( Glomerulonephritis ).

39. Clinical examples (type 111) :
1. Autoimmune disease ,(self – antigens ).
2. Chronic infections ,(microbial antigens) .
3. Cancer , (tumor antigens).
4. Drug reactions , (chemical haptens ).

40. Diagnosis (type 111) :
Demonstration of specific immune complexes in the blood or tissues by:
Immunofluoresence .

41. Type IV hypersensitivity ( delayed H/S ):
Features :
- cell-mediated (CD 4 T-cells).
- activated macrophages .
- delayed- onset (2 – 4 days).
- secondary abnormal cellular responses .
- granuloma formation .

42. Type IV H/S.
Four subtypes :
1. Basophil H/S ( Jones-mote reaction ).
2. Contact sensitivity ( chemical antigens ) .
3. Tuberculin reactions ( mantoux test )
4. Granuloma formation .

43. Mechanism of tissue damage (type 1v ):
Sensitized CD 4 Th1-cells recognize antigen.
Become activated and secrete cytokines .
Attract and activate macrophages .
This lead to intense inflammation that
cause permanent damage .

44. DTH responses to persistent antigen :
Lead to formation of a granuloma .
This prevent spread of infection e.g. T.B. tubercle .
May cause local mechanical pressure on adjacent tissues e.g. leprosy .

45. Type 1V H/S. (granuloma .)

46. Clinical examples( type 1v ):
1. Chronic infections : - T.B. - leprosy . - fungal infections . -parasitic infections. 2. Contact dermatitis .

47. Type 1V H/S. ( contact dermatitis ).

48. Diagnosis (type 1v ):
1. Delayed skin test .
2. Patch test.
3. Lymphocyte transformation test.
( detection of activation markers by flow cytometry ).

49. Patch test .